These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1124701)

  • 1. Effect of lung and gut heparin on experimental arterial thrombosis.
    Kwaan HC; Hatem A
    Adv Exp Med Biol; 1975; 52():263-8. PubMed ID: 1124701
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology and mechanics of membrane lung performance deterioration.
    Ward BD; Hood AG; Hershgold EJ
    Trans Am Soc Artif Intern Organs; 1975; 21():206-15. PubMed ID: 1145993
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Effects of heparin derived from different tissues on plasma-phospholipids and platelet aggregation.
    Gillett MP; Besterman EM
    Lancet; 1973 Nov; 2(7839):1204-5. PubMed ID: 4127572
    [No Abstract]   [Full Text] [Related]  

  • 4. Roles of blood flow in platelet adhesion and aggregation.
    Grabowski EF
    Adv Exp Med Biol; 1978; 102():73-100. PubMed ID: 98969
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of anticoagulant activity of two preparations of purified heparin.
    Baltes BJ; Diamond S; D'Agostino RJ
    Clin Pharmacol Ther; 1973; 14(2):287-90. PubMed ID: 4735188
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant activity of whale intestine heparin and its clinical application.
    Abe T; Kazama M; Matsuda M; Ikemori R; Shibata T
    Bibl Haematol; 1968; 29():1141-9. PubMed ID: 5750138
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of heparin on blood platelet aggregation and thrombus formation under the influence of a continuous electrical current].
    Mishchenko VI
    Fiziol Zh SSSR Im I M Sechenova; 1972 Nov; 58(11):1744-8. PubMed ID: 4645633
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological equivalence of beef lung and hog musosal heparins.
    Silverglade A
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):91-103. PubMed ID: 808395
    [No Abstract]   [Full Text] [Related]  

  • 10. Some effects of a microcrystalline collagen preparation on blood.
    Mason RG; Read MS
    Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulant activity of two commercially available heparin preparations. A controlled study.
    Gomez-Perez F
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):413-6. PubMed ID: 4484532
    [No Abstract]   [Full Text] [Related]  

  • 12. Inconsequentiality of surface properties for initial platelet adhesion.
    Friedman LI; Liem H; Grabowski EF; Leonard EF; McCord CW
    Trans Am Soc Artif Intern Organs; 1970; 16():63-73. PubMed ID: 5454212
    [No Abstract]   [Full Text] [Related]  

  • 13. A model of clot growth as a function of heparin and platelet concentration.
    Ramstack JM; Zuckerman L; Caprini JA; Mockros LF
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):157-66. PubMed ID: 905628
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin and vascular endothelium.
    Engelberg H
    Vasc Surg; 1977; 11(6):344-8. PubMed ID: 616148
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet and plasma coagulation compatibility of heparinized and sulphated surfaces.
    Larsson R; Eriksson JC; Lagergren H; Olsson P
    Thromb Res; 1979; 15(1-2):157-67. PubMed ID: 483273
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of platelet adhesion and aggregation by a glutardialdehyde-stabilized heparin surface.
    Olsson P; Lagergren H; Larsson R; Rådegran K
    Thromb Haemost; 1977 Apr; 37(2):274-82. PubMed ID: 577629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemostasis suppression by a combination of heparin and acetylsalicylic acid].
    Wamhoff D; Schmechel H
    Z Gesamte Inn Med; 1975 Sep; 30(18):178-80. PubMed ID: 1216936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibited platelet adhesion: a non-thrombogenic characteristic of a heparin-coated surface.
    Lagergren H; Olsson P; Swedenborg J
    Surgery; 1974 May; 75(5):643-50. PubMed ID: 4824423
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.